Elastase release during the hemodialysis procedure seems to induce changes in red blood cell membrane proteins

2011; Wiley; Volume: 15; Issue: 3 Linguagem: Inglês

10.1111/j.1542-4758.2011.00554.x

ISSN

1542-4758

Autores

Rui Pereira, Susana Rocha, Ana Pinto Borges, Henrique Nascimento, Flávio Reis, Vasco Miranda, Maria Faria, Alexandre Quintanilha, Luı́s Belo, Elı́sio Costa, Alice Santos‐Silva,

Tópico(s)

Erythrocyte Function and Pathophysiology

Resumo

Hemodialysis InternationalVolume 15, Issue 3 p. 429-431 Elastase release during the hemodialysis procedure seems to induce changes in red blood cell membrane proteins Rui PEREIRA, Rui PEREIRA Faculty of Pharmacy of Oporto University, Porto, Portugal Porto Regional Center of Portuguese Institute of Blood, Porto, PortugalSearch for more papers by this authorSusana ROCHA, Susana ROCHA Faculty of Pharmacy of Oporto University, Porto, Portugal Institute for Molecular and Cell Biology, Oporto University, Porto, PortugalSearch for more papers by this authorAna BORGES, Ana BORGES Faculty of Pharmacy of Oporto University, Porto, PortugalSearch for more papers by this authorHenrique NASCIMENTO, Henrique NASCIMENTO Faculty of Pharmacy of Oporto University, Porto, Portugal Institute for Molecular and Cell Biology, Oporto University, Porto, PortugalSearch for more papers by this authorFlávio REIS, Flávio REIS Institute of Pharmacology and Experimental Therapeutic (IBILI), University of Coimbra, Coimbra, PortugalSearch for more papers by this authorVasco MIRANDA, Vasco MIRANDA Fresenius Medical Center, Dinefro—Dialysis and Nephrology, SA, Maia, PortugalSearch for more papers by this authorMaria do SAMEIRO FARIA, Maria do SAMEIRO FARIA Institute of Pharmacology and Experimental Therapeutic (IBILI), University of Coimbra, Coimbra, PortugalSearch for more papers by this authorAlexandre QUINTANILHA, Alexandre QUINTANILHA Institute for Molecular and Cell Biology, Oporto University, Porto, Portugal Institute of Biomedical Sciences Abel Salazar, Oporto University, Porto, PortugalSearch for more papers by this authorLuís BELO, Luís BELO Faculty of Pharmacy of Oporto University, Porto, Portugal Institute for Molecular and Cell Biology, Oporto University, Porto, PortugalSearch for more papers by this authorElísio COSTA, Elísio COSTA Institute for Molecular and Cell Biology, Oporto University, Porto, Portugal Institute of Health Sciences of The Catholic University of Portugal, Porto, PortugalSearch for more papers by this authorAlice SANTOS-SILVA, Alice SANTOS-SILVA Faculty of Pharmacy of Oporto University, Porto, Portugal Institute for Molecular and Cell Biology, Oporto University, Porto, PortugalSearch for more papers by this author Rui PEREIRA, Rui PEREIRA Faculty of Pharmacy of Oporto University, Porto, Portugal Porto Regional Center of Portuguese Institute of Blood, Porto, PortugalSearch for more papers by this authorSusana ROCHA, Susana ROCHA Faculty of Pharmacy of Oporto University, Porto, Portugal Institute for Molecular and Cell Biology, Oporto University, Porto, PortugalSearch for more papers by this authorAna BORGES, Ana BORGES Faculty of Pharmacy of Oporto University, Porto, PortugalSearch for more papers by this authorHenrique NASCIMENTO, Henrique NASCIMENTO Faculty of Pharmacy of Oporto University, Porto, Portugal Institute for Molecular and Cell Biology, Oporto University, Porto, PortugalSearch for more papers by this authorFlávio REIS, Flávio REIS Institute of Pharmacology and Experimental Therapeutic (IBILI), University of Coimbra, Coimbra, PortugalSearch for more papers by this authorVasco MIRANDA, Vasco MIRANDA Fresenius Medical Center, Dinefro—Dialysis and Nephrology, SA, Maia, PortugalSearch for more papers by this authorMaria do SAMEIRO FARIA, Maria do SAMEIRO FARIA Institute of Pharmacology and Experimental Therapeutic (IBILI), University of Coimbra, Coimbra, PortugalSearch for more papers by this authorAlexandre QUINTANILHA, Alexandre QUINTANILHA Institute for Molecular and Cell Biology, Oporto University, Porto, Portugal Institute of Biomedical Sciences Abel Salazar, Oporto University, Porto, PortugalSearch for more papers by this authorLuís BELO, Luís BELO Faculty of Pharmacy of Oporto University, Porto, Portugal Institute for Molecular and Cell Biology, Oporto University, Porto, PortugalSearch for more papers by this authorElísio COSTA, Elísio COSTA Institute for Molecular and Cell Biology, Oporto University, Porto, Portugal Institute of Health Sciences of The Catholic University of Portugal, Porto, PortugalSearch for more papers by this authorAlice SANTOS-SILVA, Alice SANTOS-SILVA Faculty of Pharmacy of Oporto University, Porto, Portugal Institute for Molecular and Cell Biology, Oporto University, Porto, PortugalSearch for more papers by this author First published: 31 May 2011 https://doi.org/10.1111/j.1542-4758.2011.00554.xCitations: 2 E. Costa, Instituto de Ciências da Saúde, Universidade Católica Portuguesa, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.E-mail: [email protected], [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science. 2004; 303: 1532–1535. 2 Fitch PM, Roghanian A, Howie SEM, Sallenave JM. Human neutrophil elastase inhibitors in innate and adaptive immunity. Biochem Soc Trans. 2006; 34: 279–282. 3 Costa E, Rocha S, Rocha-Pereira P, et al. Altered erythrocyte membrane protein composition in chronic kidney disease stage 5 patients under haemodialysis and recombinant human erythropoietin therapy. Blood Purif. 2008; 26: 267–273. 4 Costa E, Rocha S, Rocha-Pereira P, et al. Changes in red blood cells membrane protein composition during haemodialysis procedure. Ren Fail. 2008; 30: 971–975. 5 Pereira R, Costa E, Gonçalves M, et al. Neutrophil and monocyte activation in chronic kidney disease patients under hemodialysis and its relationship with resistance to recombinant human erythropoietin and to the hemodialysis procedure. Hemodial Int. 2010; 14: 295–301. 6 Costa E, Rocha S, Rocha-Pereira P, et al. Neutrophil activation and resistance to recombinant human erythropoietin therapy in hemodialysis patients. Am J Nephrol. 2008; 28: 935–940. Citing Literature Volume15, Issue3July 2011Pages 429-431 ReferencesRelatedInformation

Referência(s)